QUESTCOR PHARMA INC
QCOR
QCOR was delisted on the 14th of August, 2014.
284 hedge funds and large institutions have $3.28B invested in QUESTCOR PHARMA INC in 2013 Q3 according to their latest regulatory filings, with 65 funds opening new positions, 93 increasing their positions, 105 reducing their positions, and 26 closing their positions.
150% more first-time investments, than exits
New positions opened: 65 | Existing positions closed: 26
21% more capital invested
Capital invested by funds: $2.7B → $3.28B (+$574M)
15% more funds holding
Funds holding: 247 → 284 (+37)
11% less repeat investments, than reductions
Existing positions increased: 93 | Existing positions reduced: 105
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
59% less call options, than puts
Call options by funds: $125M | Put options by funds: $302M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$48.8M |
| 2 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$32.5M |
| 3 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
+$27.5M |
| 4 |
RCAMU
Rothschild & Co Asset Management US
Stamford,
Connecticut
|
+$21.2M |
| 5 |
PA
Perceptive Advisors
New York
|
+$19.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$169M |
| 2 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$62.3M |
| 3 |
Schroder Investment Management Group
London,
United Kingdom
|
-$48.6M |
| 4 |
FCM
Freshford Capital Management
Rye Brook,
New York
|
-$26.1M |
| 5 |
VAM
Visium Asset Management
New York
|
-$23.4M |
QCOR Hedge Fund Activity: Q3 2013 in Review
284 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in QUESTCOR PHARMA INC (QCOR) for Q3 2013, worth a combined $3.28B — up 21% from $2.7B a quarter earlier.
Buyers outnumbered sellers: 65 funds opened new QCOR positions and 26 closed out — a net gain of 39 holders — while 93 added to existing stakes and 105 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $48.8M. The largest seller was Fidelity Investments, cutting an estimated $169M.
- 284 institutional investors held QUESTCOR PHARMA INC (QCOR) as of Q3 2013, up from 247 in Q2 2013.
- Funds reported $3.28B of QUESTCOR PHARMA INC stock for Q3 2013, up 21% quarter-over-quarter.
- 65 funds opened new QUESTCOR PHARMA INC positions in Q3 2013 and 26 closed out, a net change of +39 holders.
- The largest QUESTCOR PHARMA INC buyer in Q3 2013 was T. Rowe Price Associates, an estimated $48.8M added.
- The largest QUESTCOR PHARMA INC seller in Q3 2013 was Fidelity Investments, an estimated $169M sold.
Based on aggregated 13F filings for Q3 2013.